Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study

Jin Wook Lee; Eun Mi Song; Sung Ae Jung; Sung Hoon Jung; Kwang Woo Kim; Seong Joon Koh; Hyun Jung Lee; Seung Wook Hong; Jin Hwa Park; Sung Wook Hwang; Dong Hoon Yang; Byong Duk Ye; Jeong Sik Byeon; Seung Jae Myung; Suk Kyun Yang; Sang Hyoung Park

doi:10.3346/jkms.2021.36.e336

Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study

Jin Wook Lee, Eun Mi Song, Sung Ae Jung, Sung Hoon Jung, Kwang Woo Kim, Seong Joon Koh, Hyun Jung Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong Hoon Yang, Byong Duk Ye, Jeong Sik Byeon, Seung Jae Myung, Suk Kyun Yang, Sang Hyoung Park

Department of Internal Medicine

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

In 2020, the novel coronavirus disease 2019 (COVID-19) began to spread worldwide and remains an ongoing medical challenge. This case series reports on the clinical features and characteristics of patients with inflammatory bowel disease (IBD) and confirmed COVID-19 infection. From February 2020 to March 2021, nine patients with IBD had confirmed COVID-19 across four hospitals in Korea. The median age at COVID-19 diagnosis was 42 years. Six patients were male, and seven patients had ulcerative colitis (UC). No patients required oxygen therapy, intensive care unit hospitalizations, or died. The most common symptom was fever, and gastrointestinal (GI) symptoms developed as diarrhea in five patients with UC. Oral steroids were used to combat UC aggravation in two patients. In this case series of nine IBD patients diagnosed with COVID-19 in Korea, the clinical presentation was predominately a mild respiratory tract infection.

Original language	English
Article number	e336
Journal	Journal of Korean Medical Science
Volume	36
Issue number	48
DOIs	https://doi.org/10.3346/jkms.2021.36.e336
State	Published - Dec 2021

Bibliographical note

Publisher Copyright:
© 2021. The Korean Academy of Medical Sciences

Keywords

Covid 19
Crohns disease
Inflammatory bowel disease
Ulcerative colitis

Access to Document

10.3346/jkms.2021.36.e336

Cite this

Lee, J. W., Song, E. M., Jung, S. A., Jung, S. H., Kim, K. W., Koh, S. J., Lee, H. J., Hong, S. W., Park, J. H., Hwang, S. W., Yang, D. H., Ye, B. D., Byeon, J. S., Myung, S. J., Yang, S. K., & Park, S. H. (2021). Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study. Journal of Korean Medical Science, 36(48), Article e336. https://doi.org/10.3346/jkms.2021.36.e336

@article{fea91fc5947c4b37b0018a4bd02b6544,

title = "Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study",

abstract = "In 2020, the novel coronavirus disease 2019 (COVID-19) began to spread worldwide and remains an ongoing medical challenge. This case series reports on the clinical features and characteristics of patients with inflammatory bowel disease (IBD) and confirmed COVID-19 infection. From February 2020 to March 2021, nine patients with IBD had confirmed COVID-19 across four hospitals in Korea. The median age at COVID-19 diagnosis was 42 years. Six patients were male, and seven patients had ulcerative colitis (UC). No patients required oxygen therapy, intensive care unit hospitalizations, or died. The most common symptom was fever, and gastrointestinal (GI) symptoms developed as diarrhea in five patients with UC. Oral steroids were used to combat UC aggravation in two patients. In this case series of nine IBD patients diagnosed with COVID-19 in Korea, the clinical presentation was predominately a mild respiratory tract infection.",

keywords = "Covid 19, Crohns disease, Inflammatory bowel disease, Ulcerative colitis",

author = "Lee, {Jin Wook} and Song, {Eun Mi} and Jung, {Sung Ae} and Jung, {Sung Hoon} and Kim, {Kwang Woo} and Koh, {Seong Joon} and Lee, {Hyun Jung} and Hong, {Seung Wook} and Park, {Jin Hwa} and Hwang, {Sung Wook} and Yang, {Dong Hoon} and Ye, {Byong Duk} and Byeon, {Jeong Sik} and Myung, {Seung Jae} and Yang, {Suk Kyun} and Park, {Sang Hyoung}",

note = "Publisher Copyright: {\textcopyright} 2021. The Korean Academy of Medical Sciences",

year = "2021",

month = dec,

doi = "10.3346/jkms.2021.36.e336",

language = "English",

volume = "36",

journal = "Journal of Korean Medical Science",

issn = "1011-8934",

publisher = "Korean Academy of Medical Science",

number = "48",

}

Lee, JW, Song, EM , Jung, SA, Jung, SH, Kim, KW, Koh, SJ, Lee, HJ, Hong, SW, Park, JH, Hwang, SW, Yang, DH, Ye, BD, Byeon, JS, Myung, SJ, Yang, SK & Park, SH 2021, 'Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study', Journal of Korean Medical Science, vol. 36, no. 48, e336. https://doi.org/10.3346/jkms.2021.36.e336

TY - JOUR

T1 - Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea

T2 - a KASID Multicenter Study

AU - Lee, Jin Wook

AU - Song, Eun Mi

AU - Jung, Sung Ae

AU - Jung, Sung Hoon

AU - Kim, Kwang Woo

AU - Koh, Seong Joon

AU - Lee, Hyun Jung

AU - Hong, Seung Wook

AU - Park, Jin Hwa

AU - Hwang, Sung Wook

AU - Yang, Dong Hoon

AU - Ye, Byong Duk

AU - Byeon, Jeong Sik

AU - Myung, Seung Jae

AU - Yang, Suk Kyun

AU - Park, Sang Hyoung

PY - 2021/12

Y1 - 2021/12

N2 - In 2020, the novel coronavirus disease 2019 (COVID-19) began to spread worldwide and remains an ongoing medical challenge. This case series reports on the clinical features and characteristics of patients with inflammatory bowel disease (IBD) and confirmed COVID-19 infection. From February 2020 to March 2021, nine patients with IBD had confirmed COVID-19 across four hospitals in Korea. The median age at COVID-19 diagnosis was 42 years. Six patients were male, and seven patients had ulcerative colitis (UC). No patients required oxygen therapy, intensive care unit hospitalizations, or died. The most common symptom was fever, and gastrointestinal (GI) symptoms developed as diarrhea in five patients with UC. Oral steroids were used to combat UC aggravation in two patients. In this case series of nine IBD patients diagnosed with COVID-19 in Korea, the clinical presentation was predominately a mild respiratory tract infection.

AB - In 2020, the novel coronavirus disease 2019 (COVID-19) began to spread worldwide and remains an ongoing medical challenge. This case series reports on the clinical features and characteristics of patients with inflammatory bowel disease (IBD) and confirmed COVID-19 infection. From February 2020 to March 2021, nine patients with IBD had confirmed COVID-19 across four hospitals in Korea. The median age at COVID-19 diagnosis was 42 years. Six patients were male, and seven patients had ulcerative colitis (UC). No patients required oxygen therapy, intensive care unit hospitalizations, or died. The most common symptom was fever, and gastrointestinal (GI) symptoms developed as diarrhea in five patients with UC. Oral steroids were used to combat UC aggravation in two patients. In this case series of nine IBD patients diagnosed with COVID-19 in Korea, the clinical presentation was predominately a mild respiratory tract infection.

KW - Covid 19

KW - Crohns disease

KW - Inflammatory bowel disease

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=85121808171&partnerID=8YFLogxK

U2 - 10.3346/jkms.2021.36.e336

DO - 10.3346/jkms.2021.36.e336

M3 - Article

C2 - 34904410

AN - SCOPUS:85121808171

SN - 1011-8934

VL - 36

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

IS - 48

M1 - e336

ER -

Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this